When PGT Leaves No Embryo for Transfer: What to Ask Your Clinician

A cycle can end with no embryo available for transfer even when stimulation, retrieval and fertilisation appeared to go to plan. When PGT is part of the cycle, the news often arrives as a short message or a report with numbers and classifications that are hard to interpret on your own. The most useful next step is usually a scheduled conversation with the clinician who knows your cycle, armed with specific questions about the report and about what the result does and does not tell you.

This guide is about preparing that conversation. It does not interpret your result or recommend a treatment. Those decisions belong to your treating clinician and, where relevant, a genetic counsellor.

Start with the report itself

Before the appointment, ask for the full written laboratory report, not only a summary message. Read it alongside these questions:

• How many embryos were biopsied? The number tested is the denominator for everything else. A result based on one or two embryos carries different weight from one based on several.
• What happened to each embryo? Ask for a line-by-line explanation: which embryos were reported as having an abnormal chromosome number, which were reported as mosaic, which gave no result or an inconclusive result, and which were not tested at all.
• Was any embryo left untested or still in culture? Sometimes an embryo did not reach the biopsy stage, or a decision was made not to test one. Confirm whether anything remains frozen or under observation.
• What do the laboratory’s own categories mean? Thresholds and reporting categories are laboratory-specific. Ask the clinician to explain the terms used in your report rather than relying on general definitions you have read online.

PGT-A assesses chromosome number in cells sampled from an embryo, and testing has limitations: it can produce incorrect findings, and a result does not guarantee a successful pregnancy or a healthy child (HFEA: PGT-A). That matters here: a report of no transferable embryo is a statement about the sampled cells and the laboratory’s classification, not a complete account of every embryo’s potential.

If your report uses the word mosaic, ask what it meant in your case. A mosaic PGT-A result is inferred from intermediate chromosome copy-number findings in a biopsy sample, technical factors can contribute to such findings, and a sampled result does not establish the cell composition of the whole embryo (ASRM: mosaic PGT-A results). The clinician and genetic counsellor should explain what this means for your situation and what uncertainty remains.

If your testing was PGT-M or PGT-SR rather than PGT-A, the questions shift. PGT-M concerns a known monogenic condition, PGT-SR concerns chromosomal structural rearrangements, and the two address different questions; the treating team and a genetic counsellor should discuss the relevant history, test design and suitability (HFEA: PGT-M and PGT-SR). Ask whether the outcome reflects the condition the test was designed to detect, a technical limitation of the test, or something else.

Ask why, in stages

“Why did this happen?” is really several questions. Work through them in order, because the answer at each stage shapes what is worth discussing next.

1. Stimulation and retrieval. How many eggs were retrieved, how many were mature, and how does that compare with what your clinician expected for your profile?
2. Fertilisation. How many eggs fertilised, and which fertilisation method was used? Ask whether the method is being reconsidered and on what basis.
3. Development to biopsy stage. How many embryos reached the stage needed for testing? Embryo development can arrest before testing, which is a different problem from a tested embryo being classified as unsuitable.
4. The test result itself. Of those tested, how many were classified in each category, and does the pattern suggest a biological factor, a laboratory or technical factor, or chance?
5. What remains uncertain. Ask directly: is there anything in this cycle that you would investigate further before another attempt?

Factors such as maternal age, sperm factors and previous cycle history may be relevant, but only your clinician can weigh them for you. Ask which factors they consider most important in your case and why.

Discuss individual options, not a menu

There is no standard next step after a cycle with no transferable embryo. The options your clinician raises may include repeating a cycle with changes to stimulation or laboratory approach, further investigations, considering donor gametes or embryos where lawful and available, pausing treatment, or stopping. Each carries different medical, practical and emotional implications.

Useful questions include:

• What would you change in another cycle, and what evidence supports that change?
• What would you expect to be different, and what would remain uncertain?
• Are there investigations you would recommend before another cycle?
• What are the alternatives if another cycle is not something we want to pursue now?
• What is the realistic timeline for deciding, and does waiting affect anything?

Ask for the reasoning behind any recommendation, including its limits. A clinician should be able to explain why an option is being suggested for you specifically, not only in general.

Plan the conversation and the follow-up

If you are arranging care from abroad, a remote consultation may be the practical way to have this discussion. Before booking, confirm the format, who will attend, whether a genetic counsellor will be included, and what records the clinician wants in advance. Sending the full laboratory report, cycle summary and any previous treatment records ahead of time makes the conversation more productive.

During the appointment, take notes or ask permission to record. Ask for the clinician’s written summary afterwards, and confirm what has been added to your file. If you want a second opinion, request copies of the laboratory report, embryology records and cycle medication history in a format you can share.

Practical support can sit alongside the clinical conversation without replacing it. A coordination service can help organise your questions and records before the appointment, request documents from the hospital, and arrange remote consultation times. It does not interpret results or advise on treatment. If you are weighing where to continue care, background reading on how to read a PGT-A report from a Thai laboratory and on what PGT testing can and cannot change about success rates may help you frame questions, and a guide to the fertility doctor’s role during a PGT IVF cycle can clarify who is responsible for what.

If you are considering another cycle in Thailand, it is also reasonable to ask how a future frozen transfer would be planned; the parts of a frozen embryo transfer plan to confirm with your doctor lists the practical points. And if you return home before deciding, follow-up after returning home explains how to keep records and questions moving between countries.

Look after the practical and emotional side

Give yourself time before making a decision. Ask whether the clinic offers counselling or a follow-up appointment specifically to discuss the cycle, and whether a genetic counsellor is available. Write down what you understood and check it at the start of the next conversation. If you feel pressure to decide quickly, say so and ask what genuinely needs to be decided now versus later.

One cycle’s result is information, not a verdict. The purpose of the conversation is to understand what the report shows, what remains unknown, and which choices are yours to make with clinical guidance.

Frequently asked questions

Does a report of no embryo for transfer mean another cycle will have the same result?

Not necessarily. The outcome of one cycle reflects that cycle's eggs, sperm, embryo development and testing results. Your clinician can explain which factors are likely to recur and which might change with a different approach, but no one can predict a future cycle's result.

Can I ask for the laboratory report even if the clinic has already explained the result?

Yes. Asking for the full written laboratory report is reasonable and helps you prepare specific questions. A coordination service can help request the document from the hospital; interpretation remains with your treating clinician and genetic counsellor.